KALA BIO Inc.
KALA | NASDAQ
$0.55
+$0.01 (+2.04%)
At close: Sep 21, 2026, 3:59 PM ET
$0.57
+$0.02 (+3.64%)
After-hours:
Sep 21, 2026, 7:40 PM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | 3.89M | 11.24M | 6.36M |
Cost of Revenue | n/a | 259K | 303K | 2.56M | 4.1M | 3.17M |
Gross Profit | n/a | -259K | -303K | 1.33M | 7.14M | 3.19M |
Operating Income | -39.16M | -40.43M | -39.15M | -81.36M | -109.43M | -96.23M |
Interest Income | 1.14M | 2.06M | 2.71M | 664K | 104K | 493K |
Pretax Income | -26.98M | -38.51M | -42.2M | -44.82M | -142.61M | -104.33M |
Net Income | -26.98M | -38.51M | -42.2M | -44.82M | -142.61M | -104.33M |
Selling & General & Admin | 23.63M | 18.34M | 20.26M | 65.04M | 105.06M | 81.07M |
Research & Development | 18.78M | 21.84M | 18.59M | 17.65M | 11.52M | 18.35M |
Other Expenses | -3.25M | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 39.16M | 40.18M | 38.85M | 82.69M | 116.58M | 99.42M |
Interest Expense | 3.28M | 5.78M | 5.81M | 7.27M | 8.38M | 8.59M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 39.16M | 40.43M | 39.15M | 85.25M | 120.67M | 102.59M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 8.15M | 5.52M | 2.43M | 1.52M | 1.3M | 1.05M |
Shares Outstanding (Diluted) | 8.15M | 5.52M | 2.43M | 1.52M | 1.3M | 1.05M |
EPS (Basic) | -3.31 | -6.98 | -17.35 | -29.48 | -109.35 | -99.59 |
EPS (Diluted) | -3.31 | -6.98 | -17.35 | -29.48 | -109.35 | -99.59 |
EBITDA | -23.39M | -32.47M | -36.08M | -36.7M | -131.96M | -93.4M |
EBIT | -23.7M | -32.73M | -36.39M | -37.56M | -134.23M | -96.23M |
Depreciation & Amortization | 317K | 259K | 303K | 860K | 2.27M | 2.84M |
Add to Watchlist
Select watchlists to add or remove KALA